Bronchodilating effect of inhaled or orally administered calcium channel blocking agents on methacholine-induced bronchoconstriction.
Tsuda
T
T
Department of Anesthesiology & Resuscitatology, Nagoya City University, Medical School, Japan.
Takeuchi
M
M
Ishikawa
K
K
Ando
H
H
Hanamura
Y
Y
Takasu
H
H
D000280:Administration, Inhalation; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000403:Airway Resistance / Q000187:drug effects*; D001249:Asthma / Q000188:drug therapy*; D001985:Bronchial Provocation Tests / Q000379:methods*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D004110:Diltiazem / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage; D016210:Methacholine Chloride; D008688:Methacholine Compounds; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage; D014700:Verapamil / Q000008:administration & dosage
D002121:Calcium Channel Blockers; D008688:Methacholine Compounds; D016210:Methacholine Chloride; D009921:Metaproterenol; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine